Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group
| Class:Id | LiteratureReference:9613892 |
|---|---|
| _displayName | Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group |
| _timestamp | 2018-07-19 13:24:47 |
| author | [Person:9613894] Kowey, P R [Person:9613882] Levine, J H [Person:9613886] Herre, J M [Person:9613887] Pacifico, A [Person:9613885] Lindsay, B D [Person:9613876] Plumb, V J [Person:9613878] Janosik, D L [Person:9613877] Kopelman, H A [Person:9613888] Scheinman, M M |
| created | [InstanceEdit:9613883] Jassal, Bijay, 2018-07-19 |
| journal | Circulation |
| pages | 3255-63 |
| pubMedIdentifier | 7586312 |
| title | Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group |
| volume | 92 |
| year | 1995 |
| (literatureReference) | [ChemicalDrug:9613844] amiodarone [extracellular region] [Reaction:9613570] Class III (KCNA5) antiarrhythmics bind KCNA5 tetramers [Homo sapiens] [RegulationReference:9977623] Negative regulation by 'KCNA5 tetramer:Class III (KCNA5) antiarrhythmics [plasma membrane]' Dronedarone in the management of atrial fibrillation |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group (9613892)
